Paras Healthcare’s ₹1,450 crore IPO opened for subscription on October 21, 2026. Before the public issue, the company raised ₹652.5 crore from anchor investors, including domestic mutual funds and global investors.
The IPO has a price band of ₹660–₹693 per share. It includes a ₹500 crore fresh issue and a ₹950 crore Offer for Sale (OFS). A major portion of the funds raised through the fresh issue will be used for debt repayment.
Key Points:
- Issue Size: ₹1,450 crore
- Price Band: ₹660–₹693 per share
- Lot Size: 21 shares
- Minimum Investment: ₹14,553
- Opening Date: October 21, 2026
- Closing Date: October 23, 2026
- Expected Listing: October 28, 2026
- GMP: Around ₹52 (unofficial)
Paras Healthcare operates eight hospitals across North and East India. Investors should evaluate the company’s valuation, financial performance and associated risks before applying.
Disclaimer: GMP is unofficial and does not guarantee listing gains. This news is for informational purposes only and is not a Buy/Sell Recommendations.
Paras Healthcare ka ₹1,450 crore ka IPO 21 October 2026 ko subscription ke liye khul gaya hai. Public issue se pehle company ne anchor investors se ₹652.5 crore receive kiye, jisme domestic mutual funds aur global investors shamil hain.
Company ne IPO ka price band ₹660–₹693 per share rakha hai. Is issue mein ₹500 crore ka fresh issue aur ₹950 crore ka Offer for Sale (OFS) shamil hai. Fresh issue se milne wale funds ka ek major portion debt repayment ke liye use kiya jayega.
Key Points:
- Issue Size: ₹1,450 crore
- Price Band: ₹660–₹693 per share
- Lot Size: 21 shares
- Minimum Investment: ₹14,553
- Opening Date: 21 October 2026
- Closing Date: 23 October 2026
- Expected Listing: 28 October 2026
- GMP: Around ₹52 (unofficial)
Paras Healthcare North India aur East India mein 8 hospitals operate karta hai. Investors ko apply karne se pehle company ki valuation, financial performance aur risks evaluate karne chahiye.
Disclaimer: GMP unofficial hai aur listing gains ki guarantee nahi deta. Yeh news informational purpose ke liye hai, koi Buy/Sell Recommendation nahi hai.